Dr Reddys Laboratories

Rediff.com » News » Dr Reddys Laboratories

News for Dr Reddys Laboratories

News
Business

Electoral Bonds: The Quid Pro Quo Factor

Which entrepreneur would willingly part with her or his hard-earned money for grasping, self-serving politicians? asks Debashis Basu. Illustration: Uttam Ghosh/Rediff.com The State Bank of India......

How companies show electoral donations in annual reports

A reading of the reports suggests that there is no standard practice for reporting political contributions and it is left to the company's discretion to report them as they find fit. Illustration:......

Electoral bonds: Who is lottery king Santiago Martin?

Future Gaming and Hotel Services whose director is the lottery magnate Santiago Martin is the top purchaser of electoral bonds having purchased bonds worth Rs 1,368 crores, according to data......

EC reveals electoral bond donors, but not who gave which party

From the who's who of the corporate world to low-profile businesses -- the Election Commission on Thursday put out the entire list of entities that have purchased electoral bonds for making......

Electoral bonds: Congress flags mismatch in donor, recipient files

Soon after the Election Commission released electoral bonds data, the Congress on Thursday said there was a discrepancy in the numbers of entries in donor and recipient files -- 18,871 against......

Lower input costs may aid pharma firms' Q2 margins

Analysts are expecting pharmaceutical companies to post sales growth of 10-11 per cent in the second quarter this financial year while the Ebitda (earnings before interest, tax, depreciation, and......

BSE 100 companies boost R&D, innovation challenges persist

Research and development (R&D) spending by BSE 100 companies has grown steadily, rising from 0.89 per cent of revenue in FY20 to 1.32 per cent in FY24, averaging around 1 per cent over the period......

Earnings boost for Dr Reddy's Lab post consumer healthcare acquisition

Dr Reddy’s Laboratories (DRL) is set to acquire Haleon’s global portfolio of consumer healthcare brands in the nicotine replacement therapy (NRT) category outside of the US.......

Budget 2024: Wishlist of the pharma industry

There is a need to incentivise R&D investments, offer corporate tax concessions and establish an effective intellectual property rights regime in order to push the growth of domestic pharmaceutical......

Q3 result preview: US, India to aid revenue growth for Pharma Inc

The pharmaceuticals sector is expected to post a revenue growth of around 13.5 per cent and a net profit growth of 30.3 per cent for the third quarter of 2023-24 (FY24), riding on the approval for......

Rediff News

Dr Reddys Laboratories

News for Dr Reddys Laboratories

Electoral Bonds: The Quid Pro Quo Factor

How companies show electoral donations in annual reports

Electoral bonds: Who is lottery king Santiago Martin?

EC reveals electoral bond donors, but not who gave which party

Electoral bonds: Congress flags mismatch in donor, recipient files

Lower input costs may aid pharma firms' Q2 margins

BSE 100 companies boost R&D, innovation challenges persist

Earnings boost for Dr Reddy's Lab post consumer healthcare acquisition

Budget 2024: Wishlist of the pharma industry

Q3 result preview: US, India to aid revenue growth for Pharma Inc

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS